Answers are grounded in this paper and cite their sources.
This research demonstrates asymmetric transamination of α-keto phosphonates, suggesting a new way to create valuable compounds.
Chiral α-aminophosphonate derivatives are recognized as valuable compounds in both medicine and organic chemistry. Biomimetic transamination of α-keto phosphonates represents one of the most efficient strategies for accessing these pharmaceutically relevant molecules. However, establishing a general amine-transfer platform that directly delivers N-unprotected chiral α-aminophosphonates remains challenging. We report an asymmetric transamination of α-keto phosphonates catalyzed by a chiral pyridoxamine catalyst, which efficiently affords a diverse range of chiral α-aminophosphonates with up to 86% yield and 98% ee. This methodology provides a straightforward approach to biologically active α-aminophosphonic acid derivatives. Mechanistic studies, supported by DFT calculations, reveal that trifluoroethanol plays a critical role in determining the enantioselectivity and stabilizing the transition states of the rate-limiting step.
No takes yet. Share an insight, caveat, or question.
Cai et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: